91 related articles for article (PubMed ID: 19995378)
1. Quantification of radio-tracer uptake in axillary lymph nodes using breast specific gamma imaging (BSGI): benign radio-tracer extravasation versus uptake secondary to breast cancer.
Werner J; Rapelyea JA; Yost KG; Brem RF
Breast J; 2009; 15(6):579-82. PubMed ID: 19995378
[TBL] [Abstract][Full Text] [Related]
2. Metastatic axillary lymph node technetium-99m-MIBI imaging in primary breast cancer.
Taillefer R; Robidoux A; Turpin S; Lambert R; Cantin J; Léveillé J
J Nucl Med; 1998 Mar; 39(3):459-64. PubMed ID: 9529292
[TBL] [Abstract][Full Text] [Related]
3. Immunolymphoscintigraphy for the detection of lymph node metastases from breast cancer.
Tjandra JJ; Russell IS; Collins JP; Andrews JT; Lichtenstein M; Binns D; McKenzie IF
Cancer Res; 1989 Mar; 49(6):1600-8. PubMed ID: 2647290
[TBL] [Abstract][Full Text] [Related]
4. Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer?
Brenot-Rossi I; Houvenaeghel G; Jacquemier J; Bardou VJ; Martino M; Hassan-Sebbag N; Pasquier J
J Nucl Med; 2003 Aug; 44(8):1232-7. PubMed ID: 12902412
[TBL] [Abstract][Full Text] [Related]
5. [Breast carcinoma and the axillary lymph node status: the use of 99mTc-sestamibi scintimammography for the diagnosis and preoperative staging. Preliminary results].
Cistaro A; Bonazzi G; Bellò M; Bessone M; Tetti M; Villata E; Coluccia C; Bisi G; Massaioli N
Minerva Chir; 1997 Oct; 52(10):1177-82. PubMed ID: 9471568
[TBL] [Abstract][Full Text] [Related]
6. (99)mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis.
Spanu A; Dettori G; Nuvoli S; Porcu A; Falchi A; Cottu P; Solinas ME; Scanu AM; Chessa F; Madeddu G
Eur J Nucl Med; 2001 Dec; 28(12):1781-94. PubMed ID: 11734916
[TBL] [Abstract][Full Text] [Related]
7. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
[TBL] [Abstract][Full Text] [Related]
8. Implication of ¹⁸F-Fluorodeoxyglucose Uptake of Affected Axillary Lymph Nodes in Cases with Breast Cancer.
Fujii T; Yajima R; Tatsuki H; Oosone K; Kuwano H
Anticancer Res; 2016 Jan; 36(1):393-7. PubMed ID: 26722071
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node identification in breast cancer patients.
Fonti R; Limite G; Sodano A; Riccardi A; Forestieri P; De Cristofaro G; Pettinato G; Salvatore M
Radiol Med; 2002 Apr; 103(4):370-7. PubMed ID: 12107387
[TBL] [Abstract][Full Text] [Related]
10. [Preliminary study on a new sentinel lymphoscintigraphy agent 99mTc-Rituximab for breast patient].
Wang XJ; Lin BH; Yang Z; Ouyang T; Li JF; Xu B; Zhang Y; Zhang MY
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):200-3. PubMed ID: 16875605
[TBL] [Abstract][Full Text] [Related]
11. Immediate dynamic lymphoscintigraphy delivers no additional value to lymphoscintigraphy 3 hr after tracer injection in sentinel lymph node biopsy in breast cancer patients.
Doting MH; Stiekema HM; de Vries J; Lemstra C; Hoekstra HJ; Vrieling M; Rietman L; Jager PL
J Surg Oncol; 2007 May; 95(6):469-75. PubMed ID: 17192946
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node mapping for staging breast cancer: preliminary results of a prospective study.
Rehman S; Sardi A; Spiegler E; Colandrea J; Frishberg D
Md Med J; 1999; 48(3):105-10. PubMed ID: 10394225
[TBL] [Abstract][Full Text] [Related]
13. Gamma-probe-guided resection of the sentinel lymph node in breast cancer.
Crossin JA; Johnson AC; Stewart PB; Turner WW
Am Surg; 1998 Jul; 64(7):666-8; discussion 669. PubMed ID: 9655279
[TBL] [Abstract][Full Text] [Related]
14. An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation.
Feggi L; Basaglia E; Corcione S; Querzoli P; Soliani G; Ascanelli S; Prandini N; Bergossi L; Carcoforo P
Eur J Nucl Med; 2001 Nov; 28(11):1589-96. PubMed ID: 11702098
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of thin section CT scanning in the prone position of metastatic axillary lymph nodes for breast cancer].
Hata Y; Ogawa Y; Nishioka A; Inomata T; Yoshida S; Toki T
Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Dec; 56(14):1027-31. PubMed ID: 9014463
[TBL] [Abstract][Full Text] [Related]
16. Internal mammary node lymphoscintigraphy and biopsy in breast cancer.
Paganelli G; Galimberti V; Trifirò G; Travaini L; De Cicco C; Mazzarol G; Intra M; Rocca P; Prisco G; Veronesi U
Q J Nucl Med; 2002 Jun; 46(2):138-44. PubMed ID: 12114877
[TBL] [Abstract][Full Text] [Related]
17. [The value of breast lymphoscintigraphy in the definition of axillary staging in cancer of the breast].
Serin D; Vinot JM; Martin P; Reboul F; Robin M; Chevallier J
Bull Cancer; 1986; 73(3):299-304. PubMed ID: 3756366
[TBL] [Abstract][Full Text] [Related]
18. Lymphatics of the breast and the rationale for different injection techniques.
Nieweg OE
Ann Surg Oncol; 2001 Oct; 8(9 Suppl):71S-73S. PubMed ID: 11599906
[TBL] [Abstract][Full Text] [Related]
19. [A case of metastatic breast cancer showing extraosseous accumulation of 99mTc-HMDP in axillary lymph nodes on bone scintigraphy].
Endo H; Hashimoto T; Fujioka M; Murata K
Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Nov; 61(13):730-2. PubMed ID: 11766398
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of axillary lymph nodes from the results of radioisotopic study].
Rozhkova NI; Fomin DK; Smirnova NA; Mazo ML
Vestn Rentgenol Radiol; 2007; (5):13-5. PubMed ID: 18652188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
